If Neurologists Establish The Diagnosis of Primary Sjogren's Syndrome?

Neurological involvements were shown in 20% of patients with Primary Sjogren's Syndrome (pSS). Neurological symptoms may be the first signs of pSS in 57% of the cases. In addition, early diagnosis and treatment of neurological disorders may save or improve the quality of life of these cases. Th...

Full description

Saved in:
Bibliographic Details
Published inNoro-Psikiyatri Arsivi Vol. 51; no. 2; pp. 148 - 156
Main Authors Karaca, Sibel, Ersözlü Bozkirli, Emine Duygu, Karakurum Göksel, Başak, Tan, Meliha, Yücel, Ahmet Eftal
Format Journal Article
LanguageEnglish
Published Turkey Turkish Neuropsychiatric Society 01.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neurological involvements were shown in 20% of patients with Primary Sjogren's Syndrome (pSS). Neurological symptoms may be the first signs of pSS in 57% of the cases. In addition, early diagnosis and treatment of neurological disorders may save or improve the quality of life of these cases. There have been reports about the neurologic manifestations of pSS but little is known about the details of neurologically presented cases. In this study, we described 11 pSS patients who presented with neurological manifestations. Central nervous system (CNS) involvement was recorded in 7 (63.7%) and peripheric nervous system (PNS) involvement in 4 cases (36.4%). Our findings regarding the cases with neurological manifestations leading to the diagnosis of pSS suggest that: 1) The frequency of CNS involvement was higher than that of PNS, and the most frequent clinical pictures of CNS involvement are Multiple Sclerosis (MS)-like illnesses and optic neuritis, 2) Guillain Barre Syndrome (GBS) was the most frequent disease of PNS involvement; 3) Mononeuropathy multiplex (MM) might be the first sign of pSS; 4) Neurologists should consider pSS in the differential diagnosis of cases with MS, optic neuritis, GBS and neuropathies of unknown causes including MM; 5) There is an urgent need of therapeutical guidelines for the cases with neurological involvement associated with pSS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1300-0667
1309-4866
DOI:10.4274/npa.y6911